Axel Le Cesne, MD

Department of Medicine, Gustave Roussy
Villejuif, Ile-de-France, France

Presentation(s):

• Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB

  Friday, November 18, 2022
  10:30 AM – 10:38 AM

• Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA

  Friday, November 18, 2022
  4:39 PM – 4:47 PM

• Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS

  Saturday, November 19, 2022
  8:40 AM – 8:48 AM